Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 226

1.

Transcatheter Tricuspid Valve Repair With a Novel Cinching System.

Gheorghe L, Swaans M, Denti P, Rensing B, Van der Heyden J.

JACC Cardiovasc Interv. 2018 Nov 23. pii: S1936-8798(18)31933-2. doi: 10.1016/j.jcin.2018.09.019. [Epub ahead of print] No abstract available.

PMID:
30503598
2.

Clinical Implications of Distal Vessel Stenosis After Successful Coronary Chronic Total Occlusion Recanalization.

Zivelonghi C, Suttorp MJ, Teeuwen K, van Kuijk JP, van der Heyden JAS, Eefting FD, Rensing BJ, Ten Berg JM, van den Brink FS, Benfari G, Tijssen JGP, Ribichini F, Henriques JPS, Agostoni P.

JACC Cardiovasc Interv. 2018 Nov 26;11(22):2343-2345. doi: 10.1016/j.jcin.2018.07.038. No abstract available.

PMID:
30466836
3.

Insight on patient specific computer modeling of transcatheter aortic valve implantation in patients with bicuspid aortic valve disease.

Brouwer J, Gheorghe L, Nijenhuis VJ, Ten Berg JM, Rensing BJWM, van der Heyden JAS, Swaans MJ.

Catheter Cardiovasc Interv. 2018 Nov 20. doi: 10.1002/ccd.27990. [Epub ahead of print]

PMID:
30461187
4.

Implementing a minimally invasive approach (combining radial approach, small guiding catheters and minimization of double access) for coronary chronic total occlusion intervention according to the hybrid algorithm: The Minimalistic Hybrid Algorithm.

Zivelonghi C, van Kuijk JP, Suttorp MJ, van der Heyden JAS, Eefting FD, Rensing BJ, Ten Berg JM, Agostoni P.

Int J Cardiol. 2018 Nov 9. pii: S0167-5273(18)32016-3. doi: 10.1016/j.ijcard.2018.11.021. [Epub ahead of print]

PMID:
30449693
5.

Long-term results of carotid stenting and risk factors in patients with severe carotid artery stenosis undergoing subsequent cardiac surgery.

Habib N, Mahmoodi BK, Suttorp MJ, Kelder JC, Tromp SC, Sonker U, Van der Heyden J.

Catheter Cardiovasc Interv. 2018 Nov 9. doi: 10.1002/ccd.27947. [Epub ahead of print]

PMID:
30411845
6.

Transitions and trajectories in frailty states over time: a systematic review of the European Joint Action ADVANTAGE.

O'Caoimh R, Galluzzo L, Rodríguez-Laso Á, Van der Heyden J, Ranhoff AH, Carcaillon-Bentata L, Beltzer N, Kennelly S, Liew A; Work Package 5 of the Joint Action ADVANTAGE.

Ann Ist Super Sanita. 2018 Jul-Sep;54(3):246-252. doi: 10.4415/ANN_18_03_12.

7.

Incidence of frailty: a systematic review of scientific literature from a public health perspective.

Galluzzo L, O'Caoimh R, Rodríguez-Laso Á, Beltzer N, Ranhoff AH, Van der Heyden J, Lamprini-Koula M, Ciutan M, López-Samaniego L, Liew A; Work Package 5 of the Joint Action ADVANTAGE.

Ann Ist Super Sanita. 2018 Jul-Sep;54(3):239-245. doi: 10.4415/ANN_18_03_11.

8.

Prevalence of frailty at population level in European ADVANTAGE Joint Action Member States: a systematic review and meta-analysis.

O'Caoimh R, Galluzzo L, Rodríguez-Laso Á, Van der Heyden J, Ranhoff AH, Lamprini-Koula M, Ciutan M, López-Samaniego L, Carcaillon-Bentata L, Kennelly S, Liew A; Work Package 5 of the Joint Action ADVANTAGE.

Ann Ist Super Sanita. 2018 Jul-Sep;54(3):226-238. doi: 10.4415/ANN_18_03_10.

9.

Appropriate use criteria for optical coherence tomography guidance in percutaneous coronary interventions : Recommendations of the working group of interventional cardiology of the Netherlands Society of Cardiology.

IJsselmuiden AJJ, Zwaan EM, Oemrawsingh RM, Bom MJ, Dankers FJWM, de Boer MJ, Camaro C, van Geuns RJM, Daemen J, van der Heijden DJ, Jukema JW, Kraaijeveld AO, Meuwissen M, Schölzel BE, Pundziute G, van der Harst P, van Ramshorst J, Dirksen MT, Zivelonghi C, Agostoni P, van der Heyden JAS, Wykrzykowska JJ, Scholte MJ, Nef HM, Kofflard MJM, van Royen N, Alings M, Kedhi E.

Neth Heart J. 2018 Oct;26(10):473-483. doi: 10.1007/s12471-018-1143-z. Review.

10.

Survival After MitraClip Treatment Compared to Surgical and Conservative Treatment for High-Surgical-Risk Patients With Mitral Regurgitation.

Kortlandt F, Velu J, Schurer R, Hendriks T, Van den Branden B, Bouma B, Feldman T, Kelder J, Bakker A, Post M, Van der Harst P, Eefting F, Swaans M, Rensing B, Baan J Jr, Van der Heyden J.

Circ Cardiovasc Interv. 2018 Jun;11(6):e005985. doi: 10.1161/CIRCINTERVENTIONS.117.005985.

PMID:
29895598
11.

General Practice Care for Patients with Rare Diseases in Belgium. A Cross-Sectional Survey.

Boffin N, Swinnen E, Wens J, Urbina M, Van der Heyden J, Van Casteren V.

Int J Environ Res Public Health. 2018 Jun 5;15(6). pii: E1180. doi: 10.3390/ijerph15061180.

12.

Measurement agreement of the self-administered questionnaire of the Belgian Health Interview Survey: Paper-and-pencil versus web-based mode.

Braekman E, Berete F, Charafeddine R, Demarest S, Drieskens S, Gisle L, Molenberghs G, Tafforeau J, Van der Heyden J, Van Hal G.

PLoS One. 2018 May 21;13(5):e0197434. doi: 10.1371/journal.pone.0197434. eCollection 2018.

13.

Prognostic Value of Improved Kidney Function After Transcatheter Aortic Valve Implantation for Aortic Stenosis.

Nijenhuis VJ, Peper J, Vorselaars VMM, Swaans MJ, De Kroon T, Van der Heyden JAS, Rensing BJWM, Heijmen R, Bos WW, Ten Berg JM.

Am J Cardiol. 2018 May 15;121(10):1239-1245. doi: 10.1016/j.amjcard.2018.01.049. Epub 2018 Feb 12.

PMID:
29525062
14.

Randomized trial of one-hour sodium bicarbonate vs standard periprocedural saline hydration in chronic kidney disease patients undergoing cardiovascular contrast procedures.

Kooiman J, de Vries JPM, Van der Heyden J, Sijpkens YWJ, van Dijkman PRM, Wever JJ, van Overhagen H, Vahl AC, Aarts N, Verberk-Jonkers IJAM, Brulez HFH, Hamming JF, van der Molen AJ, Cannegieter SC, Putter H, van den Hout WB, Kilicsoy I, Rabelink TJ, Huisman MV.

PLoS One. 2018 Feb 8;13(2):e0189372. doi: 10.1371/journal.pone.0189372. eCollection 2018.

15.

First report of the use of long-tapered sirolimus-eluting coronary stent for the treatment of chronic total occlusions with the hybrid algorithm.

Zivelonghi C, van Kuijk JP, Nijenhuis V, Poletti E, Suttorp MJ, van der Heyden JAS, Eefting FD, Rensing BJ, Ten Berg JM, Azzalini L, van den Brink FS, Ribichini F, Colombo A, Henriques JPS, Agostoni P.

Catheter Cardiovasc Interv. 2018 Nov 1;92(5):E299-E307. doi: 10.1002/ccd.27539. Epub 2018 Feb 7.

PMID:
29411523
16.

A safe and highly efficient tumor-targeted type I interferon immunotherapy depends on the tumor microenvironment.

Cauwels A, Van Lint S, Garcin G, Bultinck J, Paul F, Gerlo S, Van der Heyden J, Bordat Y, Catteeuw D, De Cauwer L, Rogge E, Verhee A, Uzé G, Tavernier J.

Oncoimmunology. 2017 Nov 27;7(3):e1398876. doi: 10.1080/2162402X.2017.1398876. eCollection 2018.

17.

Veno-arterial extracorporeal membrane oxygenation in addition to primary PCI in patients presenting with ST-elevation myocardial infarction.

van den Brink FS, Magan AD, Noordzij PG, Zivelonghi C, Agostoni P, Eefting FD, Ten Berg JM, Suttorp MJ, Rensing BR, van Kuijk JP, Klein P, Scholten E, van der Heyden JAS.

Neth Heart J. 2018 Feb;26(2):76-84. doi: 10.1007/s12471-017-1068-y.

18.

Delivering Type I Interferon to Dendritic Cells Empowers Tumor Eradication and Immune Combination Treatments.

Cauwels A, Van Lint S, Paul F, Garcin G, De Koker S, Van Parys A, Wueest T, Gerlo S, Van der Heyden J, Bordat Y, Catteeuw D, Rogge E, Verhee A, Vandekerckhove B, Kley N, Uzé G, Tavernier J.

Cancer Res. 2018 Jan 15;78(2):463-474. doi: 10.1158/0008-5472.CAN-17-1980. Epub 2017 Nov 29.

PMID:
29187401
19.

TYK2-induced phosphorylation of Y640 suppresses STAT3 transcriptional activity.

Mori R, Wauman J, Icardi L, Van der Heyden J, De Cauwer L, Peelman F, De Bosscher K, Tavernier J.

Sci Rep. 2017 Nov 21;7(1):15919. doi: 10.1038/s41598-017-15912-6.

20.

Theranostic Radiolabeled Anti-CD20 sdAb for Targeted Radionuclide Therapy of Non-Hodgkin Lymphoma.

Krasniqi A, D'Huyvetter M, Xavier C, Van der Jeught K, Muyldermans S, Van Der Heyden J, Lahoutte T, Tavernier J, Devoogdt N.

Mol Cancer Ther. 2017 Dec;16(12):2828-2839. doi: 10.1158/1535-7163.MCT-17-0554. Epub 2017 Oct 20.

21.

Comparison of Outcome After Percutaneous Mitral Valve Repair With the MitraClip in Patients With Versus Without Atrial Fibrillation.

Velu JF, Kortlandt FA, Hendriks T, Schurer RAJ, van Boven AJ, Koch KT, Vis MM, Henriques JP, Piek JJ, Van den Branden BJL, Schaap J, Rensing BJ, Swaans MJ, Bouma BJ, Van der Heyden JAS, Baan J Jr.

Am J Cardiol. 2017 Dec 1;120(11):2035-2040. doi: 10.1016/j.amjcard.2017.08.022. Epub 2017 Aug 30.

22.

Estimating the prevalence of diabetes mellitus and thyroid disorders using medication data in Flanders, Belgium.

Vaes B, Ruelens C, Saikali S, Smets A, Henrard S, Renard F, van den Akker M, Van Pottelbergh G, Goderis G, Van der Heyden J.

Eur J Public Health. 2018 Feb 1;28(1):193-198. doi: 10.1093/eurpub/ckx106.

PMID:
29016831
23.

Feasibility of multiplane microtransoesophageal echocardiographic guidance in structural heart disease transcatheter interventions in adults.

Nijenhuis VJ, Alipour A, Wunderlich NC, Rensing BJWM, Gijsbers G, Ten Berg JM, Suttorp MJ, Boersma LVA, van der Heyden JAS, Swaans MJ.

Neth Heart J. 2017 Dec;25(12):669-674. doi: 10.1007/s12471-017-1036-6.

24.

Endovascular baroreflex amplification for resistant hypertension: a safety and proof-of-principle clinical study.

Spiering W, Williams B, Van der Heyden J, van Kleef M, Lo R, Versmissen J, Moelker A, Kroon A, Reuter H, Ansel G, Stone GW, Bates M; CALM-FIM_EUR investigators.

Lancet. 2017 Dec 16;390(10113):2655-2661. doi: 10.1016/S0140-6736(17)32337-1. Epub 2017 Sep 1.

PMID:
28870716
25.

The last frontier: transcatheter devices for percutaneous or minimally invasive treatment of chronic heart failure.

Nijenhuis VJ, Sanchis L, van der Heyden JAS, Klein P, Rensing BJWM, Latib A, Maisano F, Ten Berg JM, Agostoni P, Swaans MJ.

Neth Heart J. 2017 Oct;25(10):536-544. doi: 10.1007/s12471-017-1018-8. Review.

26.

Percutaneous Mitral Valve Repair: Refining Selection Criteria.

Velu JF, Kortlandt FA, Hendriks T, Schurer RAJ, van Boven AJ, Van den Branden BJL, Van der Heyden JAS, Bouma BJ, Rensing BJ, Baan J Jr.

J Am Coll Cardiol. 2017 Jun 13;69(23):2875-2876. doi: 10.1016/j.jacc.2017.03.602. No abstract available.

27.

Early Detection and Treatment of the Vulnerable Coronary Plaque: Can We Prevent Acute Coronary Syndromes?

Bom MJ, van der Heijden DJ, Kedhi E, van der Heyden J, Meuwissen M, Knaapen P, Timmer SAJ, van Royen N.

Circ Cardiovasc Imaging. 2017 May;10(5). pii: e005973. doi: 10.1161/CIRCIMAGING.116.005973. Review.

PMID:
28483945
28.

Sample substitution can be an acceptable data-collection strategy: the case of the Belgian Health Interview Survey.

Demarest S, Molenberghs G, Van der Heyden J, Gisle L, Van Oyen H, de Waleffe S, Van Hal G.

Int J Public Health. 2017 Nov;62(8):949-957. doi: 10.1007/s00038-017-0976-3. Epub 2017 May 3.

PMID:
28470413
29.

MAPPI-DAT: data management and analysis for protein-protein interaction data from the high-throughput MAPPIT cell microarray platform.

Gupta S, De Puysseleyr V, Van der Heyden J, Maddelein D, Lemmens I, Lievens S, Degroeve S, Tavernier J, Martens L.

Bioinformatics. 2017 May 1;33(9):1424-1425. doi: 10.1093/bioinformatics/btx014.

30.

Current MitraClip experience, safety and feasibility in the Netherlands.

Rahhab Z, Kortlandt FA, Velu JF, Schurer RAJ, Delgado V, Tonino P, Boven AJ, Van den Branden BJL, Kraaijeveld AO, Voskuil M, Hoorntje J, van Wely M, van Houwelingen K, Bleeker GB, Rensing B, Kardys I, Baan J Jr, Van der Heyden JAS, Van Mieghem NM.

Neth Heart J. 2017 Jun;25(6):394-400. doi: 10.1007/s12471-017-0992-1.

31.

Percutaneous Plug-Based Arteriotomy Closure Device for Large-Bore Access: A Multicenter Prospective Study.

Van Mieghem NM, Latib A, van der Heyden J, van Gils L, Daemen J, Sorzano T, Ligthart J, Witberg K, de Kroon T, Maor N, Mangieri A, Montorfano M, de Jaegere PP, Colombo A, Roubin G.

JACC Cardiovasc Interv. 2017 Mar 27;10(6):613-619. doi: 10.1016/j.jcin.2016.12.277.

32.

Additional weighting for education affects estimates from a National Health Interview Survey.

Van der Heyden J, De Bacquer D, Gisle L, Demarest S, Charafeddine R, Drieskens S, Tafforeau J, Van Oyen H, Van Herck K.

Eur J Public Health. 2017 Oct 1;27(5):892-897. doi: 10.1093/eurpub/ckx005.

PMID:
28204447
33.

A multicentre European registry to evaluate the Direct Flow Medical transcatheter aortic valve system for the treatment of patients with severe aortic stenosis.

Naber CK, Pyxaras SA, Ince H, Frambach P, Colombo A, Butter C, Gatto F, Hink U, Nickenig G, Bruschi G, Brueren G, Tchétché D, Den Heijer P, Schillinger W, Scholtz S, Van der Heyden J, Lefèvre T, Gilard M, Kuck KH, Schofer J, Divchev D, Baumgartner H, Asch F, Wagner D, Latib A, De Marco F, Kische S.

EuroIntervention. 2016 Dec 10;12(11):e1413-e1419. doi: 10.4244/EIJ-D-15-00511.

34.

Proteome-scale Binary Interactomics in Human Cells.

Lievens S, Van der Heyden J, Masschaele D, De Ceuninck L, Petta I, Gupta S, De Puysseleyr V, Vauthier V, Lemmens I, De Clercq DJ, Defever D, Vanderroost N, De Smet AS, Eyckerman S, Van Calenbergh S, Martens L, De Bosscher K, Libert C, Hill DE, Vidal M, Tavernier J.

Mol Cell Proteomics. 2016 Dec;15(12):3624-3639. Epub 2016 Nov 1.

35.

Echocardiographic pulmonary hypertension probability is associated with clinical outcomes after transcatheter aortic valve implantation.

Nijenhuis VJ, Huitema MP, Vorselaars VM, Swaans MJ, de Kroon T, van der Heyden JA, Rensing BJ, Heijmen R, Ten Berg JM, Post MC.

Int J Cardiol. 2016 Dec 15;225:218-225. doi: 10.1016/j.ijcard.2016.10.010. Epub 2016 Oct 6.

PMID:
27732925
36.

Increased skin autofluorescence of children and adolescents with type 1 diabetes despite a well-controlled HbA1c: results from a cohort study.

van der Heyden JC, Birnie E, Mul D, Bovenberg S, Veeze HJ, Aanstoot HJ.

BMC Endocr Disord. 2016 Sep 9;16(1):49. doi: 10.1186/s12902-016-0129-3.

37.

Regional differences in the validity of self-reported use of health care in Belgium: selection versus reporting bias.

Van der Heyden J, Charafeddine R, De Bacquer D, Tafforeau J, Van Herck K.

BMC Med Res Methodol. 2016 Aug 16;16(1):98. doi: 10.1186/s12874-016-0198-z.

38.

Microprobe transoesophageal echocardiographic guidance during transcatheter interatrial septal device implantation in heart failure with a preserved ejection fraction.

Snijder RJ, Swaans MJ, van der Heyden JA, Post MC.

EuroIntervention. 2016 Jun 20;12(3):401. doi: 10.4244/EIJV12I3A65. No abstract available.

39.

Do traditional cardiovascular risk factors solely explain intima-media thickening in youth with type 1 diabetes?

van der Heyden JC, Birnie E, Bovenberg SA, Cabezas MC, van der Meulen N, Mul D, Veeze HJ, Aanstoot HJ.

J Diabetes Complications. 2016 Aug;30(6):1137-43. doi: 10.1016/j.jdiacomp.2016.03.030. Epub 2016 Mar 31.

PMID:
27217021
40.

The predictive value of conventional surgical risk scores for periprocedural mortality in percutaneous mitral valve repair.

Kortlandt FA, van 't Klooster CC, Bakker AL, Swaans MJ, Kelder JC, de Kroon TL, Rensing BJ, Eefting FD, van der Heyden JA, Post MC.

Neth Heart J. 2016 Jul;24(7-8):475-80. doi: 10.1007/s12471-016-0841-7.

41.

Mortality after percutaneous edge-to-edge mitral valve repair: a contemporary review.

Kortlandt FA, de Beenhouwer T, Swaans MJ, Post MC, van der Heyden JA, Eefting FD, Rensing BJ.

Cardiovasc Diagn Ther. 2016 Apr;6(2):160-5. doi: 10.21037/cdt.2016.02.01. Review.

42.

A transcatheter intracardiac shunt device for heart failure with preserved ejection fraction (REDUCE LAP-HF): a multicentre, open-label, single-arm, phase 1 trial.

Hasenfuß G, Hayward C, Burkhoff D, Silvestry FE, McKenzie S, Gustafsson F, Malek F, Van der Heyden J, Lang I, Petrie MC, Cleland JG, Leon M, Kaye DM; REDUCE LAP-HF study investigators.

Lancet. 2016 Mar 26;387(10025):1298-304. doi: 10.1016/S0140-6736(16)00704-2.

PMID:
27025436
43.

Impact of Chronic Conditions and Multimorbidity on the Disability Burden in the Older Population in Belgium.

Yokota RT, Van der Heyden J, Nusselder WJ, Robine JM, Tafforeau J, Deboosere P, Van Oyen H.

J Gerontol A Biol Sci Med Sci. 2016 Jul;71(7):903-9. doi: 10.1093/gerona/glv234. Epub 2016 Jan 16.

PMID:
26774118
44.

Factors associated with excessive polypharmacy in older people.

Walckiers D, Van der Heyden J, Tafforeau J.

Arch Public Health. 2015 Nov 9;73:50. doi: 10.1186/s13690-015-0095-7. eCollection 2015.

45.

Unintentional sealing of the mitral valve with a second MitraClip. "Once bitten, twice shy".

Alipour A, Swaans MJ, Post MC, Rensing BJ, Eefting FD, Van der Heyden JA.

EuroIntervention. 2015 Sep;11(5):597. doi: 10.4244/EIJV11I5A115. No abstract available.

46.

Behavioural and neurodevelopmental outcome of 2-year-old children after preterm premature rupture of membranes: follow-up of a randomised clinical trial comparing induction of labour and expectant management.

van der Heyden JL, Willekes C, van Baar AL, van Wassenaer-Leemhuis AG, Pajkrt E, Oudijk MA, Porath MM, Duvekot HJ, Bloemenkamp KW, Groenewout M, Woiski M, Nij Bijvank B, Bax CJ, van 't Hooft J, Sikkema MJ, Akerboom BM, Mulder TA, Nijhuis JG, Mol BW, van der Ham DP.

Eur J Obstet Gynecol Reprod Biol. 2015 Nov;194:17-23. doi: 10.1016/j.ejogrb.2015.07.014. Epub 2015 Aug 3.

PMID:
26319651
47.

Long-term survival and preprocedural predictors of mortality in high surgical risk patients undergoing percutaneous mitral valve repair.

Triantafyllis AS, Kortlandt F, Bakker AL, Swaans MJ, Eefting FD, van der Heyden JA, Post MC, Rensing BW.

Catheter Cardiovasc Interv. 2016 Feb 15;87(3):467-75. doi: 10.1002/ccd.26137. Epub 2015 Aug 13.

PMID:
26268819
48.

Contribution of chronic diseases to the mild and severe disability burden in Belgium.

Yokota RT, Van der Heyden J, Demarest S, Tafforeau J, Nusselder WJ, Deboosere P, Van Oyen H.

Arch Public Health. 2015 Aug 3;73(1):37. doi: 10.1186/s13690-015-0083-y. eCollection 2015.

49.

Initial experience with therapeutic geometric modification of the carotid bulb for true resistant hypertension.

Habib N, Mahmoodi BK, Bos WJ, Tromp SC, Suttorp MJ, Bates MC, Van der Heyden J.

EuroIntervention. 2015 May;11(1):117-20. doi: 10.4244/EIJV11I1A20.

50.

The global activity limitation indicator and self-rated health: two complementary predictors of mortality.

Berger N, Van der Heyden J, Van Oyen H.

Arch Public Health. 2015 May 11;73(1):25. doi: 10.1186/s13690-015-0073-0. eCollection 2015.

Supplemental Content

Loading ...
Support Center